Proactiveinvestors United Kingdom Arix Bioscience PLC https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom Arix Bioscience PLC RSS feed en Tue, 24 Nov 2020 14:53:58 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Arix Bioscience strategy pays off big time as Merck snaps up VelosBio https://www.proactiveinvestors.co.uk/companies/news/219791/arix-bioscience-strategy-pays-off-big-time-as-merck-snaps-up-velosbio-219791.html Thu, 05 Nov 2020 15:54:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/219791/arix-bioscience-strategy-pays-off-big-time-as-merck-snaps-up-velosbio-219791.html Arix Bioscience rockets higher as Merck buys investee company VelosBio for US$2.75bn https://www.proactiveinvestors.co.uk/companies/news/933262/arix-bioscience-rockets-higher-as-merck-buys-investee-company-velosbio-for-us275bn-933262.html Thu, 05 Nov 2020 15:10:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/933262/arix-bioscience-rockets-higher-as-merck-buys-investee-company-velosbio-for-us275bn-933262.html Arix Bioscience says portfolio company LogicBio Therapeutics announces pricing for public offering https://www.proactiveinvestors.co.uk/companies/news/930495/arix-bioscience-says-portfolio-company-logicbio-therapeutics-announces-pricing-for-public-offering-930495.html Thu, 01 Oct 2020 14:47:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/930495/arix-bioscience-says-portfolio-company-logicbio-therapeutics-announces-pricing-for-public-offering-930495.html Arix Biosciences notes new data from Autolus on lymphona treatment   https://www.proactiveinvestors.co.uk/companies/news/929443/arix-biosciences-notes-new-data-from-autolus-on-lymphona-treatment--929443.html Fri, 18 Sep 2020 12:05:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/929443/arix-biosciences-notes-new-data-from-autolus-on-lymphona-treatment--929443.html Arix Bioscience enters final quarter of 2020 with strong momentum https://www.proactiveinvestors.co.uk/companies/news/928501/arix-bioscience-enters-final-quarter-of-2020-with-strong-momentum-928501.html Tue, 08 Sep 2020 09:55:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/928501/arix-bioscience-enters-final-quarter-of-2020-with-strong-momentum-928501.html Arix Bioscience portfolio company LogicBio announces IND clearance for LB-001 https://www.proactiveinvestors.co.uk/companies/news/926284/arix-bioscience-portfolio-company-logicbio-announces-ind-clearance-for-lb-001-926284.html Mon, 10 Aug 2020 14:47:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/926284/arix-bioscience-portfolio-company-logicbio-announces-ind-clearance-for-lb-001-926284.html Arix Bioscience investee company Amplyx announces positive Phase 2 data https://www.proactiveinvestors.co.uk/companies/news/924615/arix-bioscience-investee-company-amplyx-announces-positive-phase-2-data-924615.html Mon, 20 Jul 2020 13:34:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/924615/arix-bioscience-investee-company-amplyx-announces-positive-phase-2-data-924615.html Arix Bioscience says portfolio company Atox Bio plans NDA submission for Reltecimod drug in third quarter of 2020 https://www.proactiveinvestors.co.uk/companies/news/923889/arix-bioscience-says-portfolio-company-atox-bio-plans-nda-submission-for-reltecimod-drug-in-third-quarter-of-2020-923889.html Fri, 10 Jul 2020 07:52:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/923889/arix-bioscience-says-portfolio-company-atox-bio-plans-nda-submission-for-reltecimod-drug-in-third-quarter-of-2020-923889.html Arix Biosciences portfolio company VelosBio completes US$137mln Series B financing https://www.proactiveinvestors.co.uk/companies/news/923734/arix-biosciences-portfolio-company-velosbio-completes-us137mln-series-b-financing-923734.html Wed, 08 Jul 2020 13:58:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/923734/arix-biosciences-portfolio-company-velosbio-completes-us137mln-series-b-financing-923734.html Arix Bioscience PLC: Proactive One2One Virtual Event https://www.proactiveinvestors.co.uk/companies/news/921840/arix-bioscience-plc-proactive-one2one-virtual-event-921840.html Sun, 14 Jun 2020 08:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/921840/arix-bioscience-plc-proactive-one2one-virtual-event-921840.html Arix Bioscience portfolio firm Aura Biosciences presents updated data for choroidal melanoma treatment https://www.proactiveinvestors.co.uk/companies/news/921784/arix-bioscience-portfolio-firm-aura-biosciences-presents-updated-data-for-choroidal-melanoma-treatment-921784.html Fri, 12 Jun 2020 14:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/921784/arix-bioscience-portfolio-firm-aura-biosciences-presents-updated-data-for-choroidal-melanoma-treatment-921784.html Proactive meets Arix Bioscience's new chairman and hears why he's bullish on its portfolio https://www.proactiveinvestors.co.uk/companies/news/921677/proactive-meets-arix-bioscience-s-new-chairman-and-hears-why-he-s-bullish-on-its-portfolio-921677.html Thu, 11 Jun 2020 07:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/921677/proactive-meets-arix-bioscience-s-new-chairman-and-hears-why-he-s-bullish-on-its-portfolio-921677.html Arix Bioscience announces Christian Schetter’s move to a managing director role https://www.proactiveinvestors.co.uk/companies/news/921312/arix-bioscience-announces-christian-schetters-move-to-a-managing-director-role-921312.html Mon, 08 Jun 2020 08:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/921312/arix-bioscience-announces-christian-schetters-move-to-a-managing-director-role-921312.html Arix Bioscience portfolio companies Autolus and Harpoon present updates at ASCO https://www.proactiveinvestors.co.uk/companies/news/920737/arix-bioscience-portfolio-companies-autolus-and-harpoon-present-updates-at-asco-920737.html Fri, 29 May 2020 13:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/920737/arix-bioscience-portfolio-companies-autolus-and-harpoon-present-updates-at-asco-920737.html Arix Bioscience portfolio company Amplyx Pharmaceuticals raises US$53mln https://www.proactiveinvestors.co.uk/companies/news/920018/arix-bioscience-portfolio-company-amplyx-pharmaceuticals-raises-us53mln-920018.html Wed, 20 May 2020 13:22:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/920018/arix-bioscience-portfolio-company-amplyx-pharmaceuticals-raises-us53mln-920018.html Arix Bioscience's portfolio to be in spotlight at prestigious cancer event, says research house https://www.proactiveinvestors.co.uk/companies/news/919935/arix-bioscience-s-portfolio-to-be-in-spotlight-at-prestigious-cancer-event-says-research-house-919935.html Tue, 19 May 2020 11:18:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/919935/arix-bioscience-s-portfolio-to-be-in-spotlight-at-prestigious-cancer-event-says-research-house-919935.html Arix Bioscience’s Pharmaxis says myelofibrosis treatment well tolerated in clinical trial, advances to Phase 2 https://www.proactiveinvestors.co.uk/companies/news/918274/arix-biosciences-pharmaxis-says-myelofibrosis-treatment-well-tolerated-in-clinical-trial-advances-to-phase-2-918274.html Tue, 28 Apr 2020 09:01:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/918274/arix-biosciences-pharmaxis-says-myelofibrosis-treatment-well-tolerated-in-clinical-trial-advances-to-phase-2-918274.html Arix Biosciences notes investee company Harpoon's US$50mln milestone receipt https://www.proactiveinvestors.co.uk/companies/news/918200/arix-biosciences-notes-investee-company-harpoon-s-us50mln-milestone-receipt-918200.html Mon, 27 Apr 2020 13:53:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/918200/arix-biosciences-notes-investee-company-harpoon-s-us50mln-milestone-receipt-918200.html Arix Bioscience associate talks through current promising coronavirus treatments and vaccines https://www.proactiveinvestors.co.uk/companies/news/917778/arix-bioscience-associate-talks-through-current-promising-coronavirus-treatments-and-vaccines-917778.html Tue, 21 Apr 2020 15:38:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/917778/arix-bioscience-associate-talks-through-current-promising-coronavirus-treatments-and-vaccines-917778.html As Gilead news lifts world markets, Arix Bioscience expert takes look at biotech "tools" being deployed in the fight against the illness https://www.proactiveinvestors.co.uk/companies/news/917515/as-gilead-news-lifts-world-markets-arix-bioscience-expert-takes-look-at-biotech--tools--being-deployed-in-the-fight-against-the-illness-917515.html Fri, 17 Apr 2020 10:47:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/917515/as-gilead-news-lifts-world-markets-arix-bioscience-expert-takes-look-at-biotech--tools--being-deployed-in-the-fight-against-the-illness-917515.html Arix Bioscience says portfolio company Autolus to start study on leukaemia lead candidate https://www.proactiveinvestors.co.uk/companies/news/917419/arix-bioscience-says-portfolio-company-autolus-to-start-study-on-leukaemia-lead-candidate-917419.html Thu, 16 Apr 2020 12:58:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/917419/arix-bioscience-says-portfolio-company-autolus-to-start-study-on-leukaemia-lead-candidate-917419.html Arix Bioscience shuffles board, names Naseem Amin as executive chairman with immediate effect https://www.proactiveinvestors.co.uk/companies/news/916685/arix-bioscience-shuffles-board-names-naseem-amin-as-executive-chairman-with-immediate-effect-916685.html Mon, 06 Apr 2020 09:36:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/916685/arix-bioscience-shuffles-board-names-naseem-amin-as-executive-chairman-with-immediate-effect-916685.html Arix Bioscience to invest US$3.0mln in IPO by portfolio company, Imara Inc to retain 9.4% stake https://www.proactiveinvestors.co.uk/companies/news/914821/arix-bioscience-to-invest-us30mln-in-ipo-by-portfolio-company-imara-inc-to-retain-94-stake-914821.html Thu, 12 Mar 2020 08:52:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/914821/arix-bioscience-to-invest-us30mln-in-ipo-by-portfolio-company-imara-inc-to-retain-94-stake-914821.html Arix Bioscience focuses on “driving realisable value” after volatile year for markets https://www.proactiveinvestors.co.uk/companies/news/914633/arix-bioscience-focuses-on-driving-realisable-value-after-volatile-year-for-markets-914633.html Tue, 10 Mar 2020 08:56:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/914633/arix-bioscience-focuses-on-driving-realisable-value-after-volatile-year-for-markets-914633.html Arix appoints entrepreneur in residence to source European investment opportunities https://www.proactiveinvestors.co.uk/companies/news/914565/arix-appoints-entrepreneur-in-residence-to-source-european-investment-opportunities-914565.html Mon, 09 Mar 2020 12:34:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/914565/arix-appoints-entrepreneur-in-residence-to-source-european-investment-opportunities-914565.html Arix Biosciences portfolio company Aura encouraged by trial results of eye cancer treatment https://www.proactiveinvestors.co.uk/companies/news/913548/arix-biosciences-portfolio-company-aura-encouraged-by-trial-results-of-eye-cancer-treatment-913548.html Mon, 24 Feb 2020 14:05:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/913548/arix-biosciences-portfolio-company-aura-encouraged-by-trial-results-of-eye-cancer-treatment-913548.html Arix Bioscience reveals one of its portfolio companies, Imara Inc. has applied to list on Nasdaq https://www.proactiveinvestors.co.uk/companies/news/913037/arix-bioscience-reveals-one-of-its-portfolio-companies-imara-inc-has-applied-to-list-on-nasdaq-913037.html Mon, 17 Feb 2020 07:55:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/913037/arix-bioscience-reveals-one-of-its-portfolio-companies-imara-inc-has-applied-to-list-on-nasdaq-913037.html Arix Bioscience investee company Autolus publishes encouraging additional data from blood cancer drug study https://www.proactiveinvestors.co.uk/companies/news/911863/arix-bioscience-investee-company-autolus-publishes-encouraging-additional-data-from-blood-cancer-drug-study-911863.html Thu, 30 Jan 2020 12:56:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/911863/arix-bioscience-investee-company-autolus-publishes-encouraging-additional-data-from-blood-cancer-drug-study-911863.html Arix Bioscience says company co-founded in 2018 completed Series A financing, bringing total committed funding to $50mln https://www.proactiveinvestors.co.uk/companies/news/911519/arix-bioscience-says-company-co-founded-in-2018-completed-series-a-financing-bringing-total-committed-funding-to-50mln-911519.html Mon, 27 Jan 2020 08:12:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/911519/arix-bioscience-says-company-co-founded-in-2018-completed-series-a-financing-bringing-total-committed-funding-to-50mln-911519.html Arix Bioscience says portfolio company Autolus Therapeutics prices shares at US$11 each https://www.proactiveinvestors.co.uk/companies/news/911337/arix-bioscience-says-portfolio-company-autolus-therapeutics-prices-shares-at-us11-each-911337.html Thu, 23 Jan 2020 07:50:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/911337/arix-bioscience-says-portfolio-company-autolus-therapeutics-prices-shares-at-us11-each-911337.html